Patents Assigned to Mucocort AB
  • Treatment of inflammatory condition in mucous membrane or skin
    Patent number: 12544343
    Abstract: The invention relates a pharmaceutical composition comprising from 0.001 to 2% (w/v) of propane-1,2-diol as the only anti-inflammatory agent and at least one bioadhesive polymer. The pharmaceutical composition can be used in amelioration, prevention or treatment of an inflammatory condition in a mucous membrane or skin of a subject, and/or in treatment of pain associated with such an 5 inflammatory condition.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: February 10, 2026
    Assignee: Mucocort AB
    Inventors: Jean Lycke, Thomas Hedner, Mats Jontell, Olof Isaksson